drugset / Trial / NCT01559259

Evaluation of the Efficacy of Novel Ibuprofen Acetaminophen Combination Formulations in the Treatment of Post-surgical Dental Pain

NCT01559259

Phase 2 Completed 394 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will determine the overall analgesic efficacy of three different fixed dose ibuprofen plus acetaminophen formulations compared to ibuprofen alone and to placebo.

Timeline

Start
2012-04-10
Primary completion
2012-09-13
Completion
2012-09-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 500 mg
Subject Ibuprofen Small molecule 200 mg
Subject Ibuprofen Small molecule 250 mg
Subject Ibuprofen Small molecule 300 mg
Subject Ibuprofen Small molecule 400 mg

Indications

No indication recorded.